Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity

Journal of Proteome Research

Volumn 10, Issue 8, 2011, Pages 3450-3459

  Song, Jae Min ^b   Choi, Chi Won ^a   Kwon, Sang Oh ^a   Compans, Richard W ^b   Kang, Sang Moo ^b,c   Kim, Seung Il ^a  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

1 DE LC MS MS; influenza H5N1 virus like particles; proteome; vaccine

Indexed keywords

CHAPERONE; HEMAGGLUTININ; VIRUS PROTEIN;

ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CELL STRUCTURE; CYTOSKELETON; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS A H5N1; INSECT CELL; METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; TRANSLATION INITIATION; VIRUS ENVELOPE; VIRUS PARTICLE; VIRUS PURIFICATION;

ANIMALS; CELL LINE; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLUENZA A VIRUS, H5N1 SUBTYPE; MICE; MICE, INBRED BALB C; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPODOPTERA; TANDEM MASS SPECTROMETRY; VIRAL PROTEINS; VIRION;

AVES; HEXAPODA;

EID: 79961235288     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200086v     Document Type: Article

References (60)

1. Nicholson, K. G. Influenza and vaccine development: a continued battle Expert Rev. Vaccines 2009, 8 (4) 373-4
2. Pandey, A.; Singh, N.; Sambhara, S.; Mittal, S. K. Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses Hum. Vaccines 2010, 6 (2) 178-188
3. Ruat, C.; Caillet, C.; Bidaut, A.; Simon, J.; Osterhaus, A. D. Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement J. Virol. 2008, 82 (5) 2565-9 (Pubitemid 351293557)
4. Treanor, J. J.; Campbell, J. D.; Zangwill, K. M.; Rowe, T.; Wolff, M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine N. Engl. J. Med. 2006, 354 (13) 1343-51
5. Bresson, J. L.; Perronne, C.; Launay, O.; Gerdil, C.; Saville, M.; Wood, J.; Hoschler, K.; Zambon, M. C. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial Lancet 2006, 367 (9523) 1657-64 (Pubitemid 43744370)
6. Lin, J.; Zhang, J.; Dong, X.; Fang, H.; Chen, J.; Su, N.; Gao, Q.; Zhang, Z.; Liu, Y.; Wang, Z.; Yang, M.; Sun, R.; Li, C.; Lin, S.; Ji, M.; Liu, Y.; Wang, X.; Wood, J.; Feng, Z.; Wang, Y.; Yin, W. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial Lancet 2006, 368 (9540) 991-7 (Pubitemid 44353667)
7. Fan, S.; Gao, Y.; Shinya, K.; Li, C. K.; Li, Y.; Shi, J.; Jiang, Y.; Suo, Y.; Tong, T.; Zhong, G.; Song, J.; Zhang, Y.; Tian, G.; Guan, Y.; Xu, X. N.; Bu, Z.; Kawaoka, Y.; Chen, H. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates PLoS Pathog. 2009, 5 (5) e1000409
8. Jin, H.; Manetz, S.; Leininger, J.; Luke, C.; Subbarao, K.; Murphy, B.; Kemble, G.; Coelingh, K. L. Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets Vaccine 2007, 25 (52) 8664-72 (Pubitemid 350192061)
9. Suguitan, A. L., Jr; McAuliffe, J.; Mills, K. L.; Jin, H.; Duke, G.; Lu, B.; Luke, C. J.; Murphy, B.; Swayne, D. E.; Kemble, G.; Subbarao, K. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets PLoS Med. 2006, 3 (9) e360
10. Sambhara, S.; Stephenson, I. Moving influenza vaccines forward Expert Rev. Vaccines 2009, 8 (4) 375-7
11. Trollfors, B. General vaccination of children against influenza? Acta Paediatr. 2006, 95 (7) 774-7 (Pubitemid 43995520)
12. Roy, P.; Noad, R. Virus-like particles as a vaccine delivery system: myths and facts Hum. Vaccines 2008, 4 (1) 5-12 (Pubitemid 351785255)
13. Chackerian, B. Virus-like particles: flexible platforms for vaccine development Expert Rev. Vaccines 2007, 6 (3) 381-90 (Pubitemid 46911601)
14. Kang, S. M.; Song, J. M.; Quan, F. S.; Compans, R. W. Influenza vaccines based on virus-like particles Virus Res. 2009c, 143 (2) 140-6
15. Kirnbauer, R.; Booy, F.; Cheng, N.; Lowy, D. R.; Schiller, J. T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic Proc. Natl. Acad. Sci. U.S.A. 1992, 89 (24) 12180-4 (Pubitemid 23004809)
16. Garland, S. M.; Hernandez-Avila, M.; Wheeler, C. M.; Perez, G.; Harper, D. M.; Leodolter, S.; Tang, G. W.; Ferris, D. G.; Steben, M.; Bryan, J.; Taddeo, F. J.; Railkar, R.; Esser, M. T.; Sings, H. L.; Nelson, M.; Boslego, J.; Sattler, C.; Barr, E.; Koutsky, L. A. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases N. Engl. J. Med. 2007, 356 (19) 1928-43 (Pubitemid 46740303)
17. Bright, R. A.; Carter, D. M.; Crevar, C. J.; Toapanta, F. R.; Steckbeck, J. D.; Cole, K. S.; Kumar, N. M.; Pushko, P.; Smith, G.; Tumpey, T. M.; Ross, T. M. Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle PLoS ONE 2008, 3 (1) e1501
18. Haynes, J. R.; Dokken, L.; Wiley, J. A.; Cawthon, A. G.; Bigger, J.; Harmsen, A. G.; Richardson, C. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge Vaccine 2009, 27 (4) 530-41
19. Kang, S. M.; Yoo, D. G.; Lipatov, A. S.; Song, J. M.; Davis, C. T.; Quan, F. S.; Chen, L. M.; Donis, R. O.; Compans, R. W. Induction of long-term protective immune responses by influenza H5N1 virus-like particles PLoS ONE 2009, 4 (3) e4667
20. Perrone, L. A.; Ahmad, A.; Veguilla, V.; Lu, X.; Smith, G.; Katz, J. M.; Pushko, P.; Tumpey, T. M. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge J. Virol. 2009, 83 (11) 5726-34
21. Tao, P.; Luo, M.; Zhu, D.; Qu, S.; Yang, Z.; Gao, M.; Guo, D.; Pan, Z. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice Viral Immunol. 2009, 22 (4) 273-81
22. Quan, F. S.; Vunnava, A.; Compans, R. W.; Kang, S. M. Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice PLoS ONE 2010, 5 (2) e9161
23. Cantin, R.; Methot, S.; Tremblay, M. J. Plunder and stowaways: incorporation of cellular proteins by enveloped viruses J. Virol. 2005, 79 (11) 6577-87 (Pubitemid 40677289)
24. Maxwell, K. L.; Frappier, L. Viral proteomics Microbiol. Mol. Biol. Rev. 2007, 71 (2) 398-411 (Pubitemid 46954311)
25. Hoffmann, E.; Krauss, S.; Perez, D.; Webby, R.; Webster, R. G. Eight-plasmid system for rapid generation of influenza virus vaccines Vaccine 2002, 20 (25-26) 3165-70
26. Song, J. M.; Lee, Y. J.; Jeong, O. M.; Kang, H. M.; Kim, H. R.; Kwon, J. H.; Kim, J. H.; Seong, B. L.; Kim, Y. J. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea Vet. Microbiol. 2008, 130 (3-4) 268-76
27. Song, J. M.; Kim, Y. C.; Lipatov, A. S.; Pearton, M.; Davis, C. T.; Yoo, D. G.; Park, K. M.; Chen, L. M.; Quan, F. S.; Birchall, J. C.; Donis, R. O.; Prausnitz, M. R.; Compans, R. W.; Kang, S. M. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice Clin. Vaccine Immunol. 2010, 17 (9) 1381-9
28. Song, J. M.; Hossain, J.; Yoo, D. G.; Lipatov, A. S.; Davis, C. T.; Quan, F. S.; Chen, L. M.; Hogan, R. J.; Donis, R. O.; Compans, R. W.; Kang, S. M. Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles Virology 2010, 405 (1) 165-75
29. Quan, F. S.; Kim, Y. C.; Yoo, D. G.; Compans, R. W.; Prausnitz, M. R.; Kang, S. M. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin PLoS ONE 2009, 4 (9) e7152
30. Kim, Y. H.; Cho, K.; Yun, S. H.; Kim, J. Y.; Kwon, K. H.; Yoo, J. S.; Kim, S. I. Analysis of aromatic catabolic pathways in Pseudomonas putida KT 2440 using a combined proteomic approach: 2-DE/MS and cleavable isotope-coded affinity tag analysis Proteomics 2006, 6 (4) 1301-18
31. Taylor, G. K.; Goodlett, D. R. Rules governing protein identification by mass spectrometry Rapid Commun. Mass Spectrom. 2005, 19 (23) 3420 (Pubitemid 41691915)
32. Vialard, J. E.; Richardson, C. D. The 1,629-nucleotide open reading frame located downstream of the Autographa californica nuclear polyhedrosis virus polyhedrin gene encodes a nucleocapsid-associated phosphoprotein J. Virol. 1993, 67 (10) 5859-66 (Pubitemid 23277494)
33. Wilson, M. E.; Mainprize, T. H.; Friesen, P. D.; Miller, L. K. Location, transcription, and sequence of a baculovirus gene encoding a small arginine-rich polypeptide J. Virol. 1987, 61 (3) 661-6 (Pubitemid 17040190)
34. Wu, C. Y.; Yeh, Y. C.; Yang, Y. C.; Chou, C.; Liu, M. T.; Wu, H. S.; Chan, J. T.; Hsiao, P. W. Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus PLoS ONE 2010, 5 (3) e9784
35. Shaw, M. L.; Stone, K. L.; Colangelo, C. M.; Gulcicek, E. E.; Palese, P. Cellular proteins in influenza virus particles PLoS Pathog. 2008, 4 (6) e1000085
36. Kong, Q.; Xue, C.; Ren, X.; Zhang, C.; Li, L.; Shu, D.; Bi, Y.; Cao, Y. Proteomic analysis of purified coronavirus infectious bronchitis virus particles Proteome Sci. 2010, 8, 29
37. Radtke, K.; Dohner, K.; Sodeik, B. Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell Cell Microbiol. 2006, 8 (3) 387-400 (Pubitemid 43356030)
38. Gupta, S.; De, B. P.; Drazba, J. A.; Banerjee, A. K. Involvement of actin microfilaments in the replication of human parainfluenza virus type 3 J. Virol. 1998, 72 (4) 2655-62 (Pubitemid 28175499)
39. Burke, E.; Dupuy, L.; Wall, C.; Barik, S. Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus Virology 1998, 252 (1) 137-48 (Pubitemid 28564140)
40. Chertova, E.; Chertov, O.; Coren, L. V.; Roser, J. D.; Trubey, C. M.; Bess, J. W., Jr. ; Sowder, R. C., 2nd; Barsov, E.; Hood, B. L.; Fisher, R. J.; Nagashima, K.; Conrads, T. P.; Veenstra, T. D.; Lifson, J. D.; Ott, D. E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages J. Virol. 2006, 80 (18) 9039-52 (Pubitemid 44359978)
41. Chung, C. S.; Chen, C. H.; Ho, M. Y.; Huang, C. Y.; Liao, C. L.; Chang, W. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles J. Virol. 2006, 80 (5) 2127-40 (Pubitemid 43271520)
42. Varnum, S. M.; Streblow, D. N.; Monroe, M. E.; Smith, P.; Auberry, K. J.; Pasa-Tolic, L.; Wang, D.; Camp, D. G., 2nd; Rodland, K.; Wiley, S.; Britt, W.; Shenk, T.; Smith, R. D.; Nelson, J. A. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome J. Virol. 2004, 78 (20) 10960-6 (Pubitemid 39299636)
43. Johannsen, E.; Luftig, M.; Chase, M. R.; Weicksel, S.; Cahir-McFarland, E.; Illanes, D.; Sarracino, D.; Kieff, E. Proteins of purified Epstein-Barr virus Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (46) 16286-91 (Pubitemid 39552837)
44. Segura, M. M.; Garnier, A.; Di Falco, M. R.; Whissell, G.; Meneses-Acosta, A.; Arcand, N.; Kamen, A. Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations J. Virol. 2008, 82 (3) 1107-17
45. Mayer, M. P. Recruitment of Hsp70 chaperones: a crucial part of viral survival strategies Rev. Physiol. Biochem. Pharmacol. 2005, 153, 1-46 (Pubitemid 44404353)
46. Macejak, D. G.; Luftig, R. B. Association of HSP70 with the adenovirus type 5 fiber protein in infected HEp-2 cells Virology 1991, 180 (1) 120-5
47. Macejak, D. G.; Sarnow, P. Association of heat shock protein 70 with enterovirus capsid precursor P1 in infected human cells J. Virol. 1992, 66 (3) 1520-7
48. Jindal, S.; Young, R. A. Vaccinia virus infection induces a stress response that leads to association of Hsp70 with viral proteins J. Virol. 1992, 66 (9) 5357-62
49. Naeve, C. W.; Williams, D. Fatty acids on the A/Japan/305/57 influenza virus hemagglutinin have a role in membrane fusion EMBO J. 1990, 9 (12) 3857-66
50. Vester, D.; Rapp, E.; Kluge, S.; Genzel, Y.; Reichl, U. Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approach J. Proteomics 2010, 73 (9) 1656-69
51. Geeraedts, F.; Goutagny, N.; Hornung, V.; Severa, M.; de Haan, A.; Pool, J.; Wilschut, J.; Fitzgerald, K. A.; Huckriede, A. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling PLoS Pathog. 2008, 4 (8) e1000138
52. Hagenaars, N.; Mastrobattista, E.; Glansbeek, H.; Heldens, J.; van den Bosch, H.; Schijns, V.; Betbeder, D.; Vromans, H.; Jiskoot, W. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model Vaccine 2008, 26 (51) 6555-63
53. Pearton, M.; Kang, S. M.; Song, J. M.; Kim, Y. C.; Quan, F. S.; Anstey, A.; Ivory, M.; Prausnitz, M. R.; Compans, R. W.; Birchall, J. C. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin Vaccine 2010, 28 (37) 6104-13
54. Song, H.; Wittman, V.; Byers, A.; Tapia, T.; Zhou, B.; Warren, W.; Heaton, P.; Connolly, K. In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine Vaccine 2010, 28 (34) 5524-32
55. Buonaguro, L.; Tornesello, M. L.; Tagliamonte, M.; Gallo, R. C.; Wang, L. X.; Kamin-Lewis, R.; Abdelwahab, S.; Lewis, G. K.; Buonaguro, F. M. Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses J. Virol. 2006, 80 (18) 9134-43 (Pubitemid 44362963)
56. Huber, V. C.; McKeon, R. M.; Brackin, M. N.; Miller, L. A.; Keating, R.; Brown, S. A.; Makarova, N.; Perez, D. R.; Macdonald, G. H.; McCullers, J. A. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza Clin. Vaccine Immunol. 2006, 13 (9) 981-90 (Pubitemid 44518965)
57. Heusser, C. H.; Anderson, C. L.; Grey, H. M. Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line J. Exp. Med. 1977, 145 (5) 1316-27 (Pubitemid 8105374)
58. Gessner, J. E.; Heiken, H.; Tamm, A.; Schmidt, R. E. The IgG Fc receptor family Ann. Hematol. 1998, 76 (6) 231-48 (Pubitemid 28321079)
59. Jayasekera, J. P.; Moseman, E. A.; Carroll, M. C. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity J. Virol. 2007, 81 (7) 3487-94 (Pubitemid 46456657)
60. Bechtel, J. T.; Winant, R. C.; Ganem, D. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus J. Virol. 2005, 79 (8) 4952-64 (Pubitemid 40464246)